TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive NCI Provides $40 Million To Four Centers For Cancer Communications Research. June 27, 2003
TCL Archive NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding May 6, 1994
TCL Archive PRI Purchased By DynCorp; NCI Is Assured No Changes Will Be Made At Frederick April 13, 1990